NRF2 as a novel therapeutic target in early and intermediate age-related macular degeneration

ID: SR2000098

Fecha inicio

01-12-2022

Fecha fin

30-11-2025

Institutional Coordinator

253 275,00 Euros

(Total amount or amount awarded)

Cuadrado Pastor, AntonioPrincipal investigator

R&D Projects

Private project

Researchers: Cuadrado Pastor, Antonio (Investigador principal (IP))

UAM. Programa de Doctorado en Biociencias Moleculares (Doctorate Program)

UAM. Programa de Doctorado en Farmacología y Fisiología (Doctorate Program)

UAM. Facultad de Medicina. Bioquímica (University Department)